KNG1, kininogen 1, 3827

N. diseases: 279; N. variants: 24
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0458219
Disease: Complex Regional Pain Syndromes
Complex Regional Pain Syndromes
0.010 AlteredExpression disease BEFREE Recently, we developed a bradykinin reporter assay and demonstrated the differing protease activity in Complex Regional Pain Syndrome patients vs. controls. 31718985 2020
CUI: C0878544
Disease: Cardiomyopathies
Cardiomyopathies
0.010 Biomarker group BEFREE Bradykinin-potentiating factor isolated from Leiurus quinquestriatus scorpion venom alleviates cardiomyopathy in irradiated rats via remodelling of the RAAS pathway. 31664738 2020
CUI: C0001883
Disease: Airway Obstruction
Airway Obstruction
0.010 Biomarker group BEFREE Our findings show that central BK administration sensitizes cough and enhances airway obstruction via a B<sub>2</sub> receptor/TRPV1 and/or TRPA1 channels which are coupled via metabolites of COX and/or 12-LOX enzymes. 31170972 2019
CUI: C0002726
Disease: Amyloidosis
Amyloidosis
0.010 Biomarker disease BEFREE We hypothesized that bradykinin receptor inhibition alleviates the vascular dysfunction in a transgenic arcAβ mouse model of cerebral amyloidosis and that fMRI techniques can be used to monitor the treatment response. 30890928 2019
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.010 Biomarker group BEFREE Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis. 30621761 2019
CUI: C0014556
Disease: Epilepsy, Temporal Lobe
Epilepsy, Temporal Lobe
0.010 AlteredExpression disease BEFREE High levels of cleaved H-kininogen and free PKal, and low levels of C1-inhibitor (TLE = 188 ± 12 µg/mL) were observed in the serum of TLE patients. 31206169 2019
CUI: C0017636
Disease: Glioblastoma
Glioblastoma
0.010 Biomarker disease BEFREE Cytokine array analysis showed that bradykinin increases the production of interleukin (IL)-8 in GBM via B1R. 30366000 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.010 Biomarker disease BEFREE [Corrigendum] Bradykinin receptors and EphB2/EphrinB2 pathway in response to high glucose‑induced osteoblast dysfunction and hyperglycemia‑induced bone deterioration in mice. 30816429 2019
CUI: C0024143
Disease: Lupus Nephritis
Lupus Nephritis
0.010 Biomarker disease BEFREE The goal of this study was to explore the role of bradykinins and bradykinin 1 receptor (B1R) in murine lupus nephritis. 30621761 2019
CUI: C0024534
Disease: Malaria, Cerebral
Malaria, Cerebral
0.010 Biomarker disease BEFREE <b>Conclusions:</b> Our studies raise the possibility that therapeutic targeting of kinin forming enzymes and/or endothelial bradykinin receptors might reduce extent of <i>Pf</i>-iRBC sequestration and help to preserve BBB integrity in cerebral malaria (CM). 31058153 2019
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.010 Biomarker disease BEFREE In the verification tests, Kininogen-1 had a sensitivity of 95.1% and a specificity of 97.1% in SCZ prediction. 31346501 2019
CUI: C0036572
Disease: Seizures
Seizures
0.010 AlteredExpression phenotype BEFREE Human hippocampal sclerotic tissues removed after surgery for seizure control, plasma, and serum were used in the following assays: immunostaining for white blood cells in the TLE hippocampus, C-reactive protein in serum, quantification of plasma kallikrein (PKal) and cathepsin B (CatB) activity in serum and plasma, quantification of C1-inhibitor, analysis of high-molecular-weight kininogen (H-kininogen) fragments, and activation of plasma prekallikrein for comparison with healthy controls. 31206169 2019
CUI: C0038220
Disease: Status Epilepticus
Status Epilepticus
0.010 Biomarker disease BEFREE <b>Results:</b> The proteomics and ELISA results showed that the protein level of kininogen (KNG) was obviously elevated in both CSF and hippocampus, but not in serum, 5 days after the onset of SE in LiCl-Pilo chronic epilepsy model rats. 30804871 2019
CUI: C0040021
Disease: Thromboangiitis Obliterans
Thromboangiitis Obliterans
0.010 Biomarker disease BEFREE The female Wistar rats were injected with lauric acid via the femoral artery to establish the TAO model, and they were randomly divided into control group (healthy rats), model group (TAO rats) and bradykinin group (TAO rats injected with bradykinin B2 receptor-specific inhibitor). 31799689 2019
CUI: C0085096
Disease: Peripheral Vascular Diseases
Peripheral Vascular Diseases
0.010 Biomarker group BEFREE In contrast to liraglutide, GLP-1 leftward shifted the concentration relaxation curves for bradykinin in s.c. arteries from patients with peripheral arterial disease, an effect resistant to exendin-(9-39). 30403290 2019
CUI: C0206368
Disease: Exfoliation Syndrome
Exfoliation Syndrome
0.010 Biomarker disease BEFREE The concentration of complement factor 3, kininogen-1, antithrombin III and vitamin D-binding protein was increased in all eyes with PEX. 30842085 2019
CUI: C0342569
Disease: Carcinoid crisis
Carcinoid crisis
0.010 Biomarker disease BEFREE Sudden massive release of serotonin, histamine, kallikrein, and bradykinin is postulated to cause an intraoperative carcinoid crisis. 30415870 2019
CUI: C0730285
Disease: Diabetic macular edema
Diabetic macular edema
0.010 AlteredExpression disease BEFREE Western blot analysis showed that Complement 3 levels in vitreous from BK-injected eyes in rats and clinical DME samples were increased by 6.6-fold (p = 0.039) and 4.3-fold (p = 0.02), compared with their respective controls. 31351056 2019
CUI: C0748607
Disease: Recurrent seizure
Recurrent seizure
0.010 AlteredExpression disease BEFREE In patients with encephalitis, the protein level of KNG in the CSF in the postacute phase was significantly elevated in patients with a recurrent epileptic seizure during a 2-year follow-up than in patients without a recurrent seizure. 30804871 2019
CUI: C1304177
Disease: Idiopathic angioedema
Idiopathic angioedema
0.010 Biomarker disease BEFREE Angioedema can occur in isolation, accompanied by urticaria, or as a feature of anaphylaxis in mast cell-mediated disorders, bradykinin-mediated disorders, as well as in others with unknown mechanisms, such as infections, rare disorders, or idiopathic angioedema. 30679975 2019
CUI: C1621958
Disease: Glioblastoma Multiforme
Glioblastoma Multiforme
0.010 Biomarker disease BEFREE Cytokine array analysis showed that bradykinin increases the production of interleukin (IL)-8 in GBM via B1R. 30366000 2019
CUI: C3489532
Disease: Cone-Rod Dystrophy 2
Cone-Rod Dystrophy 2
0.010 Biomarker disease BEFREE To explore this idea a potent bradykinin B2 receptor antagonist HOE-140 was used in our rat model of SCI and cord pathology. 31349925 2019
CUI: C3714636
Disease: Pneumonitis
Pneumonitis
0.010 Biomarker disease BEFREE This study suggests that kininogen could contribute to HDM-induced rise in Penh independently of allergic lung inflammation. 30358441 2019
CUI: C4317109
Disease: Epileptic Seizures
Epileptic Seizures
0.010 AlteredExpression phenotype BEFREE In patients with encephalitis, the protein level of KNG in the CSF in the postacute phase was significantly elevated in patients with a recurrent epileptic seizure during a 2-year follow-up than in patients without a recurrent seizure. 30804871 2019
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.010 Biomarker disease BEFREE The responsiveness of the stellate cells to bradykinin was markedly reduced in experimental alcohol-related acute pancreatitis, but they became sensitive to stimulation with trypsin. 29424931 2018